Alphatec Holdings [ATEC] vs Boston Scientific [BSX] Detailed Stock Comparison
Alphatec Holdings
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Alphatec Holdings wins in 6 metrics, Boston Scientific wins in 12 metrics, with 0 ties. Boston Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alphatec Holdings | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -13.98 | 61.76 | Alphatec Holdings |
| Price-to-Book Ratio | 96.91 | 6.85 | Boston Scientific |
| Debt-to-Equity Ratio | 1,238.29 | 53.09 | Boston Scientific |
| PEG Ratio | 2.03 | 0.42 | Boston Scientific |
| EV/EBITDA | -184.98 | 34.95 | Alphatec Holdings |
| Profit Margin (TTM) | -24.33% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | -6.19% | 18.63% | Boston Scientific |
| EBITDA Margin (TTM) | N/A | 18.63% | N/A |
| Return on Equity | -376.89% | 11.55% | Boston Scientific |
| Return on Assets (TTM) | -7.61% | 5.39% | Boston Scientific |
| Free Cash Flow (TTM) | $-137.79M | $2.37B | Boston Scientific |
| 1-Year Return | 177.53% | 32.89% | Alphatec Holdings |
| Price-to-Sales Ratio (TTM) | 3.41 | 8.31 | Alphatec Holdings |
| Enterprise Value | $2.78B | $164.42B | Boston Scientific |
| EV/Revenue Ratio | 4.07 | 8.89 | Alphatec Holdings |
| Gross Profit Margin (TTM) | 69.58% | 67.65% | Alphatec Holdings |
| Revenue per Share (TTM) | $5 | $13 | Boston Scientific |
| Earnings per Share (Diluted) | $-1.13 | $1.68 | Boston Scientific |
| Beta (Stock Volatility) | 1.05 | 0.66 | Boston Scientific |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alphatec Holdings vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alphatec Holdings | 0.25% | 2.31% | 54.51% | 25.83% | 50.14% | 75.83% |
| Boston Scientific | -0.79% | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alphatec Holdings | 177.53% | 103.45% | 165.94% | 145.83% | -37.97% | -83.24% |
| Boston Scientific | 32.89% | 159.65% | 156.42% | 516.34% | 1,816.39% | 301.11% |
Performance & Financial Health Analysis: Alphatec Holdings vs Boston Scientific
| Metric | ATEC | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $2.32B | $153.73B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,404,930 | 6,087,580 |
| 90 Day Avg. Volume | 2,525,720 | 7,069,760 |
| Last Close | $15.93 | $105.21 |
| 52 Week Range | $4.88 - $16.07 | $78.30 - $108.94 |
| % from 52W High | -0.87% | -3.42% |
| All-Time High | $105.60 (Jun 12, 2006) | $108.94 (Jul 23, 2025) |
| % from All-Time High | -84.91% | -3.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.28% | 0.23% |
| Quarterly Earnings Growth | 0.27% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | -0.24% | 0.14% |
| Operating Margin (TTM) | -0.06% | 0.19% |
| Return on Equity (TTM) | -3.77% | 0.12% |
| Debt to Equity (MRQ) | 1,238.29 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.16 | $15.14 |
| Cash per Share (MRQ) | $1.06 | $0.36 |
| Operating Cash Flow (TTM) | $15.69M | $4.28B |
| Levered Free Cash Flow (TTM) | $21.17M | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Alphatec Holdings vs Boston Scientific
| Metric | ATEC | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -13.98 | 61.76 |
| Forward P/E | -24.15 | 37.19 |
| PEG Ratio | 2.03 | 0.42 |
| Price to Sales (TTM) | 3.41 | 8.31 |
| Price to Book (MRQ) | 96.91 | 6.85 |
| Market Capitalization | ||
| Market Capitalization | $2.32B | $153.73B |
| Enterprise Value | $2.78B | $164.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.07 | 8.89 |
| Enterprise to EBITDA | -184.98 | 34.95 |
| Risk & Other Metrics | ||
| Beta | 1.05 | 0.66 |
| Book Value per Share (MRQ) | $0.16 | $15.14 |
Financial Statements Comparison: Alphatec Holdings vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ATEC | BSX |
|---|---|---|
| Revenue/Sales | $169.18M | $4.66B |
| Cost of Goods Sold | $53.18M | $1.45B |
| Gross Profit | $116.00M | $3.21B |
| Research & Development | $16.58M | $443.00M |
| Operating Income (EBIT) | $-31.71M | $937.00M |
| EBITDA | $-10.19M | $1.23B |
| Pre-Tax Income | $-51.97M | $805.00M |
| Income Tax | $-64,000 | $133.00M |
| Net Income (Profit) | $-51.91M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ATEC | BSX |
|---|---|---|
| Cash & Equivalents | $153.24M | $725.00M |
| Total Current Assets | $434.89M | $7.34B |
| Total Current Liabilities | $157.87M | $5.06B |
| Long-Term Debt | $572.40M | $10.93B |
| Total Shareholders Equity | $-85.94M | $22.45B |
| Retained Earnings | $-1.33B | $3.35B |
| Property, Plant & Equipment | $320.90M | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ATEC | BSX |
|---|---|---|
| Operating Cash Flow | $-23.48M | $513.00M |
| Capital Expenditures | $-9.93M | $-187.00M |
| Free Cash Flow | $-16.65M | $277.00M |
| Debt Repayment | $-321.03M | $-1.31B |
| Common Stock Repurchase | $-3.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ATEC | BSX |
|---|---|---|
| Shares Short | 12.68M | 16.27M |
| Short Ratio | 8.50 | 2.15 |
| Short % of Float | 0.10% | 0.01% |
| Average Daily Volume (10 Day) | 3,404,930 | 6,087,580 |
| Average Daily Volume (90 Day) | 2,525,720 | 7,069,760 |
| Shares Outstanding | 144.13M | 1.47B |
| Float Shares | 116.01M | 1.48B |
| % Held by Insiders | 0.21% | 0.00% |
| % Held by Institutions | 0.69% | 0.94% |
Dividend Analysis & Yield Comparison: Alphatec Holdings vs Boston Scientific
| Metric | ATEC | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |